VBrain

FDA cleared AI-powered brain tumor auto contouring solution
VBrain

VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.

Brain Metastasis
Brain Metastasis
Meningioma
Meningioma
Acoustic Neuroma
Acoustic Neuroma

Product Features

Proprietary AI technology and first-ever FDA clearance

VBrain uses a proprietary artificial intelligence algorithm to contour (segment) brain tumors on MRI images and is the first solution ever cleared by the FDA for AI-powered tumor auto-contouring in radiotherapy.

Spot tiny lesions and accelerate contouring workflows by 30.8%

VBrain demonstrates 12.2 percent higher sensitivity for lesion detection while decreasing treatment planning time at a median of 30.8 percent. Increased accuracy and efficiency of all clinicians is remarkably proven with less experienced clinicians exhibiting the most distinct improvements utilizing VBrain’s assistance.

Seamless integration with existing workflows

VBrain is vendor-neutral, seamlessly integrating with any treatment planning system by supporting data routing to and from DICOM nodes within a hospital network. An administration interface manages data routing rules and the configuration of workflows.